2022. Complement C1QC as a potential prognostic marker and therapeutic target in colon carcinoma based on single-cell RNA sequencing and immunohistochemical analysis. Biomolecules and Biomedicine. 22, 6 (Oct. 2022), 912–922. DOI:https://doi.org/10.17305/bjbms.2022.7309.